Cannabiceps

A Deep Dive into Scientific Exploration

In the dynamic realm of modern medicine, it’s crucial to approach natural treatments with a rigorous lens. Just as important as it is to trust ancient traditions and remedies, it’s equally vital to scrutinize and verify their effectiveness through contemporary scientific methods.

As you navigate comprehensive repository of studies focused on the therapeutic potential of cannabinoids, you’ll uncover an extensive compilation of research studies that delve into the multifaceted interactions and health benefits of this intriguing compound.

Historically, the potential of cannabinoids was touted in age-old traditions and ancient cultures. Today, with the advancement of scientific research techniques, we have the capability to not only understand the mechanisms by which cannabinoids operate but also to explore their implications across a wide range of health conditions.

The following studies are a testament to the commitment of the scientific community to demystify the properties of cannabinoids. Researchers from around the world have dedicated their expertise to investigating its effects, from cellular interactions to its potential role in symptom management and disease modulation.

Here, you’ll find investigations into conditions as varied as chronic pain, mental health disorders, neurological ailments, metabolic disorders, cancers, and so much more. Each study sheds light on the potential pathways by which cannabinoids might exert their effects, offering hope and insight to those seeking alternative therapeutic solutions.

It’s essential to approach each study with an open mind and a critical eye. As with all scientific research, it’s the collective body of evidence, rather than individual studies, that help shape our understanding. We encourage you to delve into these studies, understand the methodologies employed, the conclusions reached, and the implications suggested.

As CANNABICEPS continues its journey, we remain staunch advocates for marrying ancient wisdom with modern science. Our hope is that this compilation serves as a valuable resource for those eager to explore the science behind the anecdotal accounts, to make informed decisions, and to understand the expansive potential of what nature has provided us.

We invite you to embark on this journey of discovery, understanding, and hope.

Study References

STUDY: A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson’s Disease

CONDITIONS: Parkinson’s Disease

LINK: https://clinicaltrials.gov/study/NCT02818777

STUDY: An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Adults With Dravet or Lennox-Gastaut Syndromes

CONDITIONS: Epilepsy, Dravet Syndrome, Lennox-Gastaut Syndrome

LINK: https://clinicaltrials.gov/study/NCT02224573

STUDY: Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults

CONDITIONS: Epilepsy, Lennox Gastaut Syndrome

LINK: https://clinicaltrials.gov/study/NCT02224560

STUDY: A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)

CONDITIONS: Ulcerative Colitis

LINK: https://clinicaltrials.gov/study/NCT01562314

STUDY: University of Alabama at Birmingham (UAB) Pediatric CBD Program

CONDITIONS: Epilepsy, Seizures

LINK: https://clinicaltrials.gov/study/NCT02695537

STUDY: An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

CONDITIONS: Tuberous Sclerosis Complex, Seizures

LINK: https://clinicaltrials.gov/study/NCT02544750

STUDY: GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome

CONDITIONS: Epilepsy, Dravet Syndrome

LINK: https://clinicaltrials.gov/study/NCT02224703

STUDY: Oral Cannabidiol for Opioid Withdrawal

CONDITIONS: Opioid Withdrawal, Opioid Craving, Opioid Use Disorder

LINK: https://clinicaltrials.gov/study/NCT04238754

STUDY: Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)

CONDITIONS: Epilepsy, Dravet Syndrome

LINK: https://clinicaltrials.gov/study/NCT02091375

STUDY: Characterization of the Analgesic Effect of CBD in Healthy, Normal Volunteers

CONDITIONS: Pain

LINK: https://clinicaltrials.gov/study/NCT02751359

STUDY: Trial of Cannabis for Essential Tremor

CONDITIONS: Essential Tremor

LINK: https://clinicaltrials.gov/study/NCT03805750

STUDY: Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana

CONDITIONS: Smoking, Marijuana

LINK: https://clinicaltrials.gov/study/NCT01844687

STUDY: Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7)

CONDITIONS: Infantile Spasms

LINK: https://clinicaltrials.gov/study/NCT02954887

STUDY: A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome

CONDITIONS: Rett Syndrome, RTT

LINK: https://clinicaltrials.gov/study/NCT04252586

STUDY: A Study to Test the Pharmacodynamic, Pharmacokinetic, Safety, and Tolerability of Padsevonil in Healthy Study Participants Receiving Either Ethanol or Cannabidiol

CONDITIONS: Healthy Participants

LINK: https://clinicaltrials.gov/study/NCT04039919

STUDY: A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis

CONDITIONS: Multiple Sclerosis, Spasticity

LINK: https://clinicaltrials.gov/study/NCT01610687

STUDY: Pilot Study of the Safety and Efficacy of Four Different Potencies of Smoked Marijuana in 76 Veterans With PTSD

CONDITIONS: Posttraumatic Stress Disorder

LINK: https://clinicaltrials.gov/study/NCT02759185

STUDY: Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)

CONDITIONS: Infantile Spasms

LINK: https://clinicaltrials.gov/study/NCT02953548

STUDY: Cannabidiol Treatment in Patients With Early Psychosis

CONDITIONS: Schizophrenia, Schizoaffective Disorder

LINK: https://clinicaltrials.gov/study/NCT02504151

STUDY: Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome

CONDITIONS: Rett Syndrome, RTT

LINK: https://clinicaltrials.gov/study/NCT03848832

STUDY: A Study of Cannabis Based Medicine Extracts and Placebo in Patients With Pain Due to Spinal Cord Injury

CONDITIONS: Pain

LINK: https://clinicaltrials.gov/study/NCT01606202

STUDY: A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic Disorder

CONDITIONS: Schizophrenia, Schizophrenia-related Psychotic Disorder

LINK: https://clinicaltrials.gov/study/NCT02006628

STUDY: Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder

CONDITIONS: Seizures

LINK: https://clinicaltrials.gov/study/NCT02318602

STUDY: Novel Cognitive Treatment Targets for Epidiolex in Sturge-Weber Syndrome

CONDITIONS: Sturge-Weber Syndrome

LINK: https://clinicaltrials.gov/study/NCT04447846

STUDY: A Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Participants With Prader-Willi Syndrome

CONDITIONS: Prader-Willi Syndrome

LINK: https://clinicaltrials.gov/study/NCT03458416

STUDY: A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1)

CONDITIONS: Epilepsy, Dravet Syndrome

LINK: https://clinicaltrials.gov/study/NCT02091206

STUDY: Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic Dermatitis

CONDITIONS: Atopic Dermatitis

LINK: https://clinicaltrials.gov/study/NCT03824405

STUDY: A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

CONDITIONS: Tuberous Sclerosis Complex, Seizures

LINK: https://clinicaltrials.gov/study/NCT02544763

STUDY: Clinical Study Of caNNabidiol in childrEn and adolesCenTs With Fragile X (CONNECT-FX)

CONDITIONS: Fragile X Syndrome

LINK: https://clinicaltrials.gov/study/NCT03614663

STUDY: An Open-label Extension Study to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol

CONDITIONS: Epilepsy

LINK: https://clinicaltrials.gov/study/NCT02564952

STUDY: Acute and Short-term Effects of Cannabidiol Admin on Cue-induced Craving in Drug-abstinent Heroin Dependent Humans

CONDITIONS: Opiate Addiction

LINK: https://clinicaltrials.gov/study/NCT01605539

STUDY: A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol

CONDITIONS: Epilepsy

LINK: https://clinicaltrials.gov/study/NCT02565108

STUDY: The Use of Cannabidiol (CBD) in Pain Reduction and Opioid Use After Shoulder Arthroscopy

CONDITIONS: Pain, Postoperative

LINK: https://clinicaltrials.gov/study/NCT04672252

STUDY: A Study to Assess the Effect of Cannabidiol Oil on Pain After Ureteroscopy for Kidney Stones

CONDITIONS: Urinary Stone

LINK: https://clinicaltrials.gov/study/NCT04387617

STUDY: Effects of Cannabidiol in Alcohol Use Disorder

CONDITIONS: Alcohol Use Disorder

LINK: https://clinicaltrials.gov/study/NCT03252756

STUDY: A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults

CONDITIONS: Epilepsy, Lennox-Gastaut Syndrome

LINK: https://clinicaltrials.gov/study/NCT02224690

STUDY: The Effects of Cannabidiol on the Driving Ability of Healthy Adults

CONDITIONS: Driving Performance, Cognitive Impairment, Sedation Complication, Mood

LINK: https://clinicaltrials.gov/study/NCT04590495

STUDY: Evaluation of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris

CONDITIONS: Acne Vulgaris

LINK: https://clinicaltrials.gov/study/NCT03573518

STUDY: A Study to Assess Cannabidiol Oral Solution With Vigabatrin as Initial Therapy in Participants With Infantile Spasms

CONDITIONS: Infantile Spasm

LINK: https://clinicaltrials.gov/study/NCT03421496

STUDY: A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin

CONDITIONS: Pain, Multiple Sclerosis

LINK: https://clinicaltrials.gov/study/NCT01606176

STUDY: Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome

CONDITIONS: Sturge-Weber Syndrome

LINK: https://clinicaltrials.gov/study/NCT02332655

STUDY: Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms

CONDITIONS: Spasms, Infantile

LINK: https://clinicaltrials.gov/study/NCT02551731

STUDY: Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures

CONDITIONS: Childhood Absence Epilepsy

LINK: https://clinicaltrials.gov/study/NCT03336242

STUDY: University of Alabama at Birmingham (UAB) Adult CBD Program

CONDITIONS: Epilepsy, Seizures

LINK: https://clinicaltrials.gov/study/NCT02700412

STUDY: GWMD1092 – GWP42003 : GWP42004 Together Plus Alone in Type II Diabetes

CONDITIONS: Dyslipidemias, Diabetes Mellitus, Type 2

LINK: https://clinicaltrials.gov/study/NCT01217112

STUDY: Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia

CONDITIONS: Schizophrenia, Schizoaffective Disorder

LINK: https://clinicaltrials.gov/study/NCT00588731

STUDY: Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis

CONDITIONS: Spasticity in Participants With Multiple Sclerosis

LINK: https://clinicaltrials.gov/study/NCT04657666

STUDY: Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi Syndrome

CONDITIONS: Prader-Willi Syndrome

LINK: https://clinicaltrials.gov/study/NCT02844933

STUDY: Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders

CONDITIONS: Seizures

LINK: https://clinicaltrials.gov/study/NCT02324673

STUDY: A Study to Compare Sublingual Cannabis Based Medicine Extracts With Placebo to Treat Brachial Plexus Injury Pain

CONDITIONS: Pain

LINK: https://clinicaltrials.gov/study/NCT01606189

STUDY: Cannabidiol as a Treatment for AUD Comorbid With PTSD

CONDITIONS: Alcohol Use Disorder, Post Traumatic Stress Disorder

LINK: https://clinicaltrials.gov/study/NCT03248167

STUDY: Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures

CONDITIONS: Childhood Absence Epilepsy

LINK: https://clinicaltrials.gov/study/NCT03355300

STUDY: An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients

CONDITIONS: Multiple Sclerosis

LINK: https://clinicaltrials.gov/study/NCT01610700

STUDY: Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment

CONDITIONS: Schizophrenia

LINK: https://clinicaltrials.gov/study/NCT04421456

STUDY: Study to Evaluate the Effect of GWP42003 on Liver Fat Levels in Participants With Fatty Liver Disease

CONDITIONS: Fatty Liver

LINK: https://clinicaltrials.gov/study/NCT01284634

STUDY: Acute and Short-term Effects of CBD on Cue-induced Craving in Drug-abstinent Heroin-dependent Humans

CONDITIONS: Opiate Addiction

LINK: https://clinicaltrials.gov/study/NCT02539823

STUDY: Cannabidiol Pharmacotherapy for Adults With Cannabis Use Disorder

CONDITIONS: Cannabis Use Disorder

LINK: https://clinicaltrials.gov/study/NCT03102918

STUDY: Investigation of Cannabidiol for Reduction of NeuroInflammation in Chronic Back Pain

CONDITIONS: Back Pain, Low

LINK: https://clinicaltrials.gov/study/NCT03891264

STUDY: The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children With Severe Epilepsy

CONDITIONS: Lennox-Gastaut Syndrome, Dravet Syndrome

LINK: https://clinicaltrials.gov/study/NCT02815540

STUDY: Cannabidiol and Emotional Stimuli

CONDITIONS: Drug Addiction

LINK: https://clinicaltrials.gov/study/NCT02902081

STUDY: An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis

CONDITIONS: Multiple Sclerosis

LINK: https://clinicaltrials.gov/study/NCT01610713

STUDY: Cannabidiol Use to Reduce Cravings in Individuals With Opioid Use Disorder on Buprenorphine

CONDITIONS: Opioid-use Disorder

LINK: https://clinicaltrials.gov/study/NCT04192370